New Institutional Portfolio Stakes
Ranger Investment Management Discloses $67 Million in New Q2 Portfolio Stakes
Key Points
Chime Financial (CHYM) becomes a notable holding for Ranger with a new stake of 1,188,661 shares valued at about $24.34 million, representing roughly 1.5% of Ranger’s portfolio and ranking as its 21st-largest position.
BlackRock added a new stake in ADMA Biologics during the second quarter, with exposure valued at about $321 million, underscoring substantial institutional interest alongside Ranger’s new position.
ADMA Biologics is highly institutionally owned, with about 75.68% of the stock held by institutional investors and hedge funds, according to the report.
Analysts have adjusted Permian Resources' price targets in Q2, with Raymond James lowering to $26 and Citigroup reducing to $24, while both firms maintain a Buy rating for the stock.
In Tetra Technologies, Ranger’s new stake coincides with notable insider activity: CEO Brady M. Murphy sold 50,000 shares on July 1, and VP Kurt Hallead purchased 22,000 shares on June 9.
Ranger Investment Management deployed roughly $67 million across five companies in Q2, signaling a broad expansion into financials, biotech, energy, and water infrastructure. The investment firm's largest bet went to Chime Financial (CHYM) with a $24.3 million stake, followed by a new $17.7 million position in biotechnology company ADMA Biologics Watchlist News.
The move reflects heightened institutional activity in these stocks, with other major funds also adjusting holdings during the same period. Ranger's portfolio now includes new positions in Permian Resources ($15.0 million), Tetra Technologies ($5.19 million), and Select Water Solutions ($4.79 million) Watchlist News.
Chime Becomes Ranger's 21st-Largest Holding
Ranger purchased 1,188,661 shares of fintech company Chime Financial, making it a notable position worth roughly $24.34 million. The stake represents about 1.5% of Ranger's total portfolio and ranks as its 21st-largest position Watchlist News.
ADMA Biologics Attracts Major Institutional Money
Ranger's new $17.7 million investment in ADMA Biologics adds to substantial institutional interest in the biotech firm. The company is highly institutionally owned, with about 75.68% of shares held by institutional investors and hedge funds Watchlist News.
BlackRock separately established a new stake in ADMA during Q2 valued at about $321 million, underscoring the level of institutional attention the company is receiving Watchlist News.
Energy Holdings Face Analyst Pressure on Price Targets
Ranger's $15.0 million investment in Permian Resources comes as major analysts adjusted their price targets downward in Q2. Raymond James lowered its target to $26, while Citigroup reduced it to $24, though both firms kept Buy ratings on the stock Watchlist News.
In Tetra Technologies, Ranger's new $5.19 million position coincides with mixed insider moves. CEO Brady M. Murphy sold 50,000 shares on July 1, while VP Kurt Hallead purchased 22,000 shares on June 9 Watchlist News.
Water Infrastructure Gets New Institutional Backing
Ranger established its smallest new position in Select Water Solutions with 239,795 shares valued at approximately $4.79 million. The investment represents Ranger's entry into the water infrastructure sector during a period of broad capital deployment Watchlist News.
Sentiment
Mostly PositivePublishers
23
Articles
2
Reach
25
